SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015774
Filing Date
2023-04-28
Accepted
2023-04-28 16:06:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa_14a_proxy.htm DEFA14A 20504
2 GRAPHIC img93579786_0.jpg GRAPHIC 771468
3 GRAPHIC img93579786_1.jpg GRAPHIC 563352
  Complete submission text file 0000950170-23-015774.txt   1860101
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38662 | Film No.: 23865972
SIC: 2836 Biological Products, (No Diagnostic Substances)